Ceftriaxone sodium CAS:74578-69-1
Ceftriaxone sodium is prescribed by healthcare providers for the treatment of various infections, including respiratory tract infections, urinary tract infections, meningitis, septicemia, Lyme disease, and gonorrhea. The dosage, frequency of administration, and duration of ceftriaxone sodium therapy are determined based on the type and severity of the infection, as well as individual patient factors. Patients typically receive ceftriaxone sodium via intravenous or intramuscular injection under medical supervision to ensure proper dosing and monitoring of treatment response. It is essential to adhere to the prescribed dosing regimen and complete the full course of treatment to effectively eradicate the infection and reduce the risk of recurrence. While generally well-tolerated, common side effects of ceftriaxone sodium may include gastrointestinal disturbances, allergic reactions, or injection site reactions. Patients should be monitored for adverse reactions during treatment, and any significant or persistent side effects should be promptly reported to a healthcare provider for evaluation and management. Ceftriaxone sodium is a crucial antibiotic in clinical practice for combating bacterial infections when used appropriately under medical guidance.
Composition | C18H19N8NaO7S3 |
Assay | 99% |
Appearance | white powder |
CAS No. | 74578-69-1 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |